• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: PHILIPS NORTH AMERICA LLC MX40 1.4 GHZ SMART HOPPING

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

PHILIPS NORTH AMERICA LLC MX40 1.4 GHZ SMART HOPPING Back to Search Results
Model Number 865350
Device Problem Alarm Not Visible (1022)
Patient Problem Low Oxygen Saturation (2477)
Event Date 04/01/2022
Event Type  Injury  
Manufacturer Narrative
A follow up report will be submitted once the investigation is complete.
 
Event Description
The customer reports that they entered the patient's room and noted that patient's oxygen saturation was 46, and that alarm was off on the bedside monitor.The patient was immediately placed on 100% nrb (non-rebreather mask), hospital staff was notified.Oxygen saturation rebounded to 100% but patient remained minimally responsive, eventually becoming more alert.The venous blood gas (vbg) showed hypercarbia.The patient was placed on bipap machine and transferred to intensive care unit (icu).The device was in use on a patient at the time of event.There was an adverse event reported.The nurse confirmed that the patient's o2 sat was 46, and failed to alert of the drop in oxygen saturation.
 
Event Description
The customer reports that they entered the patient's room and noted that patient's oxygen saturation was 46, and that alarm was off on the bedside monitor.The patient was immediately placed on 100% nrb (non-rebreather mask), hospital staff was notified.Oxygen saturation rebounded to 100% but patient remained minimally responsive, eventually becoming more alert.The venous blood gas (vbg) showed hypercarbia.The patient was placed on bipap machine and transferred to intensive care unit (icu).The device was in use on a patient at the time of event.There was an adverse event reported.The nurse confirmed that the patient's o2 sat was 46, and failed to alert of the drop in oxygen saturation.The service engineer was dispatched to the customer site to assess the clinical logs.The service engineer reviewed the logs and confirmed that the mx40 overrode the bedside settings, therefore, turning off the spo2 alarm when the patient was being moved to another central station.The product support engineer confirmed that it is normal behavior of the telemetry device to override the bedside device if the telemetry device is being used as the source of the ecg measurement.Based on the information provided by the field service engineer (fse) the issue resolved after changing the configuration at the piic ix central station, to always have spo2 alarms set to on by default.It was it is concluded that the reported problem was the result of an incorrect configuration.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
MX40 1.4 GHZ SMART HOPPING
Type of Device
MX40 1.4 GHZ SMART HOPPING
Manufacturer (Section D)
PHILIPS NORTH AMERICA LLC
3000 minuteman road
andover MA 01810
Manufacturer (Section G)
PHILIPS NORTH AMERICA LLC
3000 minuteman road
andover MA 01810
Manufacturer Contact
jeanne ahearn
222 jacobs st
cambridge, MA 02141
6172455900
MDR Report Key14193251
MDR Text Key289969499
Report Number1218950-2022-00360
Device Sequence Number1
Product Code DSI
UDI-Device Identifier00884838082236
UDI-Public00884838082236
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K113125
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Health Professional,User Facility
Reporter Occupation Biomedical Engineer
Type of Report Initial,Followup
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Model Number865350
Device Catalogue Number865350
Was Device Available for Evaluation? Yes
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 04/01/2022
Initial Date FDA Received04/25/2022
Supplement Dates Manufacturer Received09/22/2022
Supplement Dates FDA Received10/17/2022
Was Device Evaluated by Manufacturer? No
Date Device Manufactured04/22/2020
Is the Device Single Use? No
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Reuse
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age66 YR
Patient SexFemale
-
-